Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

15-01-2022 | Original Article

Initial Severity and Depressive Relapse in Cognitive Behavioral Therapy and Antidepressant Medications: An Individual Patient Data Meta-analysis

Tijdschrift:
Cognitive Therapy and Research
Auteurs:
Jay C. Fournier, Nicholas R. Forand, Zheng Wang, Zhexuan Li, Satish Iyengar, Robert J. DeRubeis, Richard Shelton, Jay Amsterdam, Robin B. Jarrett, Jeffrey R. Vittengl, Zindel Segal, Sona Dimidjian, M. Tracie Shea, Keith S. Dobson, Steven D. Hollon
Belangrijke opmerkingen

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s10608-021-10281-x.
Jay C. Fournier and Nicholas R. Forand have contributed equally as first authors of this manuscript.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

Background

Baseline severity has emerged as a key predictor of acute response to treatments for depression. The goals of this individual patient data meta-analysis were to compare the relapse prevention effects of acute phase cognitive behavioral therapy (CBT) vs. acute phase antidepressant medications (ADM) either continued (-c) or discontinued (-d) and determine whether baseline depression severity moderated these effects.

Methods

We included all available relevant randomized trials of CBT versus ADM in adult outpatients with depression. Cox proportional hazards models were used to examine whether treatment condition, baseline severity, and additional characteristics were associated with relapse.

Results

Using individual participant data from 5 of 10 published trials (N = 341), CBT (HR = 0.38, 95% CI 0.26–0.57) and ADM-c (HR = 0.48, 95% CI 0.29–0.80) were superior to ADM-d in preventing relapse over 12 months but did not differ from each other (HR = 1.26, 95% CI 0.76–2.09). Baseline severity did not moderate these effects.

Conclusions

Regardless of a patient’s baseline symptom severity, CBT and ADM-c both prevent depressive relapse substantially better than medication discontinuation. Given the shorter duration of treatment and equivalent longer-term outcomes, treatment with CBT might be considered a first choice for adults with depression.

Log in om toegang te krijgen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Psychologie Totaal

Met BSL Psychologie Totaal blijf je als professional steeds op de hoogte van de nieuwste ontwikkelingen binnen jouw vak. Met het online abonnement heb je toegang tot een groot aantal boeken, protocollen, vaktijdschriften en e-learnings op het gebied van psychologie en psychiatrie. Zo kun je op je gemak en wanneer het jou het beste uitkomt verdiepen in jouw vakgebied.

Extra materiaal
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
Over dit artikel